Moraxella catarrhalis in chronic obstructive pulmonary disease: Burden of disease and immune response

American Journal of Respiratory and Critical Care Medicine

Volumn 172, Issue 2, 2005, Pages 195-199

  Murphy, Timothy F ^a   Brauer, Aimee L ^b   Grant, Brydon J B ^b   Sethi, Sanjay ^b  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

Chronic bronchitis; Mucosal immunity; Respiratory tract infection

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MOLECULAR TYPING; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; SPUTUM CULTURE;

AGED; ANTIBODY FORMATION; CARRIER STATE; COST OF ILLNESS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; TIME FACTORS;

EID: 22144452196     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200412-1747OC     Document Type: Article

References (29)

1. Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state of the art review. Clin Microbiol Rev 2001;14: 336-363.
2. Wilson R. The role of infection in COPD. Chest 1998;113:242S-248S.
3. Tager I, Speizer FE. Role of infection in chronic bronchitis. N Engl J Med 1975;292:563-571.
4. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000;109:288-295.
5. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflammation and bronchial microbial patterns with stable chronic obstructive pulmonary disease. Eur Respir J 1999;14:1015-1022.
6. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-S121.
7. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
8. May JR. The bacteriology of chronic bronchitis. Lancet 1953;12:534-537.
9. Howell TH. Chronic bronchitis. London, UK: Butterworth; 1951.
10. Smith CB, Golden C, Klauber MR, Kanner R, Renzetti A. Interactions between viruses and bacteria in patients with chronic bronchitis. J Infect Dis 1976;134:552-561.
11. Gump DW, Phillips CA, Forsyth BR, McIntosh FK, Lamborn KR, Stouch WH. Role of infection in chronic bronchitis. Am Rev Respir Dis 1976;113:465-473.
12. McHardy VU, Inglis JM, Calder MA, Crofton JW. A study of infective and other factors in exacerbations of chronic bronchitis. Br J Dis Chest 1980;74:228-238.
13. Zalacain R, Sobradillo V, Amilibia J, Barron J, Achotegui V, Pijoan JI, Llorente JL. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 1999;13:343-348.
14. Vaneechoutte M, Verschraegen G, Claeys G, Weise B, Van Den Abeele AM. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol 1990;28:2674-2680.
15. Pollard JA, Wallace RJ Jr, Nash DR, Luman JI, Wilson RW. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Drugs 1986;31:103-108.
16. Elmes PC, Knox K, Fletcher CM. Sputum in chronic bronchitis: effects of antibiotics. Lancet 1953;265:903-906.
17. Sethi S, Evans N, Grant BJB, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-471.
18. Bakri F, Brauer AL, Sethi S, Murphy TF. Systemic and mucosal antibody response to Moraxella catarrhalis following exacerbations of chronic obstructive pulmonary disease. J Infect Dis 2002;185:632-640.
19. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.
20. Andersen P, Therneau T. Cox's regression model for counting processes: a large sample study. Ann Statist 1982;10:1100-1120.
21. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-526.
22. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002;121:121S-126S.
23. Murphy TF, Brauer AL, Schiffmacher AT, Sethi S. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:266-272.
24. Groeneveld K, Van Alphen L, Voorter C, Eijk PP, Jansen HM, Zanen HC. Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease. Infect Immun 1989;57:3038-3044.
25. Hiltke TJ, Sethi S, Murphy TF. Sequence stability of the gene encoding outer membrane protein P2 of nontypeable Haemophilus influenzae in the human respiratory tract. J Infect Dis 2002;185:627-631.
26. Varon E, Levy C, De La Rocque F, Boucheral M, Deforche D, Podglajen I, Navel M, Cohen R. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections. Clin Infect Dis 2000;31:477-481.
27. Langan CE, Cranfield R, Breisch S, Pettit R. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis. J Antimicrob Chemother 1997; 40:63-72.
28. Murphy TF. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol Rev 1996;60:267-279.
29. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146:1067-1083.